IKCC statement on the negative opinion by the CHMP for the ipilimumab/nivolumab combination
The International Kidney Cancer Coalition (IKCC) have released the following [...]
Results from 2017 National Cancer Patient Experience Survey are the best ever
With survival rates at an all-time high, the National Cancer [...]
Latest clinical trial results for the treatment of kidney cancer
These short videos explain the latest results from the following [...]
Negative EMA opinion for the ipilimumab/nivolumab combination
Yesterday it was announced that the combination of ipilimumab and [...]
Diabetes raises risk of cancer, especially for women
A recent global review, published in Diabetologia (the journal of the European [...]
Integrative versus alternative cancer therapy: Know the difference and which can help
This blog, published in Cure recently, discusses the difference between [...]
How exercise can help cancer patients
This fact sheet, produced by Cancer Therapy Advisor, reviews how [...]
Nivolumab is safe and effective for older kidney cancer patients
Findings from an expanded access programme giving 389 metastatic renal [...]
The implications of germline mutations in kidney cancer
A recent article in JAMA Oncology, published this month, discusses [...]
Be Clear on Cancer Blood in Pee campaign launched
Public Health England (PHE) has launched a national ‘Be Clear [...]
